Griffith University microbiologist Dr Kate Seib has been recognised for her distinguished contributions to microbiology research in Australia, including vaccine targets for diseases which cause meningitis, gonorrhoea and middle ear infections.
Dr Kate Seib has recently been awarded a NHMRC Career Development Fellowship for her research into bacteria-related disease which may lead to the development of vaccines.
Vaginal microbes are at the centre of a novel discovery that aims to investigate if these bacteria trap HIV or act as a courier service to deliver the virus to the host within the human body.
Griffith University researchers will lead 17 new Discovery Projects across a broad field of knowledge after being awarded over $7.735 million from the Australian Research Council.
Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.
We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).
Griffith University’s Institute for Glycomics celebrates the promotion of six of its researchers, in recognition of their outstanding contributions to...
Some of Griffith University’s most outstanding research students have been acknowledged at the Institute for Glycomics Student Scholarships Awards evening....
Key Griffith University research projects have received $4.5 million in funding from the National Health and Medical Research Council. Announced...
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical...
